General Information of the Compound
Compound ID |
CP0457475
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
3-[(1E)-1-[8-[(4-chloro-2-cyclopropylimidazo[4,5-c]pyridin-1-yl)methyl]-3-fluoro-6H-benzo[c][1]benzoxepin-11-ylidene]ethyl]-4H-1,2,4-oxadiazol-5-one
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C28H21ClFN5O3
|
||||||||||||||||||
Molecular Weight |
529.959
|
||||||||||||||||||
Canonical SMILES |
C\C(c1noc(=O)[nH]1)=C1\c2ccc(Cn3c(nc4c(Cl)nccc34)C3CC3)cc2COc2cc(F)ccc12
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C28H21ClFN5O3/c1-14(26-33-28(36)38-34-26)23-19-6-2-15(10-17(19)13-37-22-11-18(30)5-7-20(22)23)12-35-21-8-9-31-25(29)24(21)32-27(35)16-3-4-16/h2,5-11,16H,3-4,12-13H2,1H3,(H,33,34,36)/b23-14+
Show/Hide
|
||||||||||||||||||
InChIKey |
NUPZFGWAEISNLL-OEAKJJBVSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound